Method: Determination of NtAb titers was evaluated using the following SARS-CoV-2 variants: B.1.1.1 (PMVL-1,
S:
D614G; hCoV-19/Russia/Moscow_PMVL-1/2020), B.1.1.7 (hCoV-19/Netherlands/NoordHolland_20432/2020, VOC 202012/01), B.1.351 (hCoV-19/Russia/SPE-RII-27029S/2021), B.1.1.141 (PMVL-31,
S:
M153T,
T385I,
D614G; hCoV-19/Russia/MOW-PMVL-31/2020), B.1.1.317 (PMVL-43,
S:
D138Y,
S477N,
A522S,
D614G,
Q675R,
A845S; hCoV-19/Russia/MOW-PMVL-43/2021), B.1.1.28/P.1 (hCoV-19/Netherlands/NoordHolland_10915/2021), B.1.617.2 (
T19R